Life Sciences Archives - Page 4 of 17 - Becker's Hospital Review

FDA approves new COVID shot | GSK to pay $2B for liver disease drug | GLP-1s may lower cancer risk: Study | HHS sets drug price targets

May 21, 2025 BHR Newsletter 1. Novo Nordisk to develop new obesity pills as CEO exits Full story 2. FDA approves Novavax COVID-19 shot, adds restrictions Full story 3. Children's Mercy + UAB share how to spot AI-driven employee scams…

Zepbound beats Wegovy in weight loss | Cell therapy gets FDA designation | Moderna's combo shot bests standard vaccines | New blood pressure drug shows promise

May 14, 2025 BHR Newsletter 1. Zepbound beats Wegovy for weight loss: Study Full story 2. Moderna’s flu-COVID vaccine beats standard shots: Study Full story 3. Cyber threats rising — how LCMC Health is futureproofing EHR recovery here. 4. UW…

Tariffs stall US investment | J&J immune disorder drug approved | FDA's chief inspector abruptly resigns | 6 drugs in shortage

May 7, 2025 BHR Newsletter 1. FDA green-lights J&J immune disorder drug Full story 2. Tariffs stall US investment: Pfizer CEO Full story 3. Speed, value, adoption — how 3 health systems made ambient AI work at scale here. 4.…

Bristol Myers' drug fails study | 1st pediatric patient receives gene therapy | Drug approvals to watch | FDA requests new trial for COVID shot

April 30, 2025 BHR Newsletter 1. Bristol Myers' schizophrenia drug fails key study Full story 2. Medicaid plans often restrict diabetes therapies with heart benefits: Study Full story 3. What's driving stronger reimbursement strategies in '25? Find out — here. 4.…

Glenmark recalls 24 US drugs | Eli Lilly to make weight loss pill in US | FDA layoffs stall drug development | DOGE's access to HHS

April 23, 2025 BHR Newsletter 1. Eli Lilly to make weight loss pill in US Full story 2. Glenmark recalls 24 US drugs: 4 notes Full story 3. DOGE has access to 19 HHS systems: Report Full story 4. Rising…

Tariffs endanger heparin supply | Pfizer drops GLP-1 drug | FDA to replace animal drug testing | The new norm in diabetes care

April 16, 2025 BHR Newsletter 1. Pfizer discontinues GLP-1 weight loss drug Full story 2. Tariffs may threaten lifesaving heparin supply Full story 3. CivicaScript to offer discounted droxidopa Full story 4. Multidisciplinary excellence: Learn how Fox Chase Cancer Center…

FDA plans fewer drug inspections | Mounjaro beats out Trulicity in study | Shingles vaccine cuts dementia risk | Potential barriers to Elevidys

April 9, 2025 BHR Newsletter 1. After patient’s death, study cites potential barrier to Elevidys Full story 2. Mounjaro outperforms Trulicity in glucose control, weight loss: Study Full story 3. Medicare will not cover GLP-1s for weight loss: 3 notes…

Eli Lilly deepens direct-to-consumer strategy | Ovarian cancer drug, study says | Rybelsus lowers cardiovascular risk in trial | Mount Sinai launches AI center | 6 GLP-1 updates

April 2, 2025 BHR Newsletter 1. Study finds new drug effective against treatment-resistant ovarian cancer Full story 2. Eli Lilly moves to expand Zepbound access Full story 3. Mount Sinai launches new AI center Full story 4. AI and claim…

New therapy delays Alzheimer's | Novo Nordisk buys weight loss drug for $2B | Drug shortages may jump 25% | Medicaid cuts threaten 477K healthcare jobs

March 26, 2025 BHR Newsletter 1. Novo Nordisk to pay up to $2B for experimental weight loss drug Full story 2. Anti-amyloid therapy shows promise in delaying Alzheimer's in at-risk patients Full story 3. Medicaid cuts could cost 477,000 healthcare…

1st death in muscular dystrophy treatment | HIV drug gives yearlong protection | New stroke drug tests favorable | Ozempic may help with aging

March 19, 2025 BHR Newsletter 1. Zepbound, Wegovy fail to justify prices: Study Full story 2. 1st patient death in muscular dystrophy treatment Full story 3. HIV drug could offer yearlong protection with a single shot Full story 4. Baptist…